#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12408	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2110	576.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1670	1670	T	635	T,C,G	598,7,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12408	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2110	576.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1404	1404	C	710	C	694	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23304	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3579	642.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1691	1691	A	745	A,G	723,10	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23304	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3579	642.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2325	2325	C	729	C,T	708,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23304	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3579	642.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2399	2399	A	747	A	737	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23304	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3579	642.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2951	2951	C	689	C,A	672,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	35206	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1865	1866.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1692	folP	855	855	99.88	folP.l15.c4.ctg.1	1715	97.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1076	1078	AGC	166;166;167	A;G;C	163;162;163	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4790	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3451	137.0	0	.	p	.	0	G95A	NONSYN	283	285	GGC	647	649	GCC	134;131;134	G;C,A;C	131;127,1;129	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4790	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3451	137.0	1	SNP	p	S91F	1	.	.	271	273	TTC	635	637	TTC	140;142;141	T;T,C;C	136;136,1;134	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1478	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1369	106.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	466	468	ACC	160;162;161	A,G;C,A;C,G	149,1;155,1;157,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1478	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1369	106.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	664	666	CAC	174;173;172	C;A;C	172;168;167	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1478	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1369	106.4	0	.	p	.	0	A127fs	FSHIFT	379	379	G	730	730	G	163	GCCCC,GCC	155,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1478	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1369	106.4	1	SNP	p	G45D	0	.	.	133	135	GGC	484	486	GGC	157;154;157	G;G,A;C	153;148,1;154	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	880	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	966	88.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1495	1497	GTC	147;147;143	G;T;C	144;137;139	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	156;156;160	G;A;C	152;149;157	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	1	SNP	p	R87I	0	.	.	259	261	CGT	604	606	CGT	160;162;162	C;G,C;T	158;158,1;153	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	1	SNP	p	R87W	0	.	.	259	261	CGT	604	606	CGT	160;162;162	C;G,C;T	158;158,1;153	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	1	SNP	p	S87R	1	.	.	259	261	CGT	604	606	CGT	160;162;162	C;G,C;T	158;158,1;153	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3930	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3010	128.6	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	164;163;162	T;C;C	159;158;159	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3586	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2739	129.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1536	1538	GGC	206;203;199	G;G;C,A	202;202;197,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1224	1226	GCA	178;179;178	G;C;A,C	172;175;173,1	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1227	1229	ATC	179;181;184	A;T;C,G	172;176;179,1	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1239	1241	GTG	194;195;196	G,A;T,C;G,C	190,1;188,1;189,1	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1239	1241	GTG	194;195;196	G,A;T,C;G,C	190,1;188,1;189,1	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1743	1745	ACC	156;154;153	A;C;C	149;153;152	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1797	1799	GCG	139;138;132	G;C,G;G	132;121,1;125	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1797	1799	GCG	139;138;132	G;C,G;G	132;121,1;125	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1920	1922	GGT	116;113;112	G;G;T	114;112;111	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1929	1931	GGC	114;113;111	G,A;G;C	110,2;111;110	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3242	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2357	135.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1947	1949	CCG	95;96;96	C,G;C;G	76,3;82;81	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4826	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3220	148.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1705	1707	CCG	172;175;174	C,G;C,T,G;G,C	157,1;166,2,1;163,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2170	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1999	106.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	605	605	C	150	C,G	142,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	786	788	GGA	171;174;176	G;G;A	169;172;166	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	0	.	p	.	0	.	INDELS	629	630	AA	989	991	TAG	172;175;175	T;A;G	163;175;165	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	993	996	CAAT	178;180;181;185	C;A;A;T	173;173;180;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	998	998	T	184	T	183	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	1	SNP	p	G120K	0	.	.	358	360	GGT	717	719	GGT	187;186;186	G,A;G,A;T,G,C	183,2;182,2;175,2,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	1	SNP	p	A121N	0	.	.	361	363	GCC	720	722	GCC	182;180;183	G,A,T;C,A;C	176,2,1;176,2;180	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2442	porB1b	1035	1035	98.94	porB1b.l6.c30.ctg.1	1576	150.3	1	SNP	p	A121D	0	.	.	361	363	GCC	720	722	GCC	182;180;183	G,A,T;C,A;C	176,2,1;176,2;180	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8522	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4811	174.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2028	2030	AAT	189;187;187	A,C;A;T	183,2;181;182	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1016	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1247	80.2	1	SNP	p	V57M	1	.	.	169	171	ATG	717	719	ATG	193;194;190	A;T;G	189;190;187	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	M177T	NONSYN	529	531	ATG	878	880	ACG	347;343;340	A,G;C,T;G	336,1;335,2;334	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	899	901	GAC	317;322;323	G;A;C	314;317;322	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	T190M	NONSYN	568	570	ACG	917	919	ATG	306;307;305	A;T;G	306;306;303	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	L194S	NONSYN	580	582	TTA	929	931	TCA	295;295;294	T;C;A	292;294;294	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	974	976	CAG	304;303;304	C;A;G	303;302;304	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	V216L	NONSYN	646	648	GTT	995	997	CTT	300;303;300	C;T;T	297;302;298	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1016	1018	AGT	315;316;315	A;G;T,A	312;311;307,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1085	1087	CCG	339;336;337	C;C;G	331;328;327	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1187	1189	TCG	381;383;386	T;C;G	374;374;375	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1358	1360	AAA	211;213;208	A;A;A	209;211;207	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1361	1363	AAG	208;206;207	A;A;G	207;204;205	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1376	1378	CAC	191;191;192	C;A;C	191;183;192	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1415	1417	GAA	213;216;220	G;A;A	210;216;218	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1493	1495	ACG	170;169;167	A;C;G	169;169;167	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1544	1546	ATT	233;233;232	A;T;T	233;233;232	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1547	1549	AGT	232;229;226	A;G;T	232;229;225	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1586	1588	CTA	229;229;233	C;T;A	228;228;231	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1628	1630	AAT	155;158;161	A;A;T	154;158;160	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1697	1699	TCA	238;241;241	T;C;A,T	236;241;232,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1721	1723	ATG	252;249;247	A;T;G	248;248;245	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2015	2017	ACC	431;431;430	A;C,A;C	417;421,1;421	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8144	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2711	296.3	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2111	2113	GAA	416;413;416	G;A;A	414;411;413	.	Tetracycline resistance
